91 |
|
The size of venture capital and private equity fund portfolios
|
Bernile, G.; Cumming, D.; Lyandres, E.
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|
92 |
|
Governance indexes and valuation: Which causes which?
|
Lehn, K.; Patro, S.; Zhao, M.
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|
93 |
|
Are family firms really superior performers?
|
Miller, D.; Le Breton-Miller, I.; Lester, R. H.; Cannella, A. A.
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|
94 |
|
SEC Regulation Fair Disclosure, information, and the cost of capital
|
Gomes, A.; Gorton, G.; Madureira, L.
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|
95 |
|
Corporate precautionary cash holdings
|
Han, S.; Qiu, J.
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|
96 |
|
Editorial Board
|
unknown
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|
97 |
|
Unlocking value: Equity carve outs as strategic real options
|
Perotti, E.; Rossetto, S.
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|
98 |
|
The value relevance of top executive departures: Evidence from the Netherlands
|
Cools, K.; Mirjam van Praag, C.
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|
99 |
|
Editorial Board
|
unknown
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|
100 |
|
Evaluating the boundaries of SEC regulation
|
Smith, J. K.
|
Elsevier Science B.V., Amsterdam.
|
2007
|
|
|